<!DOCTYPE html>
<html lang="ko">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pritamab ì„±ëŠ¥ ë¶„ì„ ì¢…í•© ë³´ê³ ì„œ</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Malgun Gothic', 'Apple SD Gothic Neo', sans-serif;
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 40px 20px;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            border-radius: 20px;
            box-shadow: 0 20px 60px rgba(0, 0, 0, 0.15);
            overflow: hidden;
        }

        /* Header */
        .header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 60px 40px;
            text-align: center;
        }

        .header h1 {
            font-size: 48px;
            margin-bottom: 15px;
            text-shadow: 2px 2px 4px rgba(0, 0, 0, 0.2);
        }

        .header p {
            font-size: 20px;
            opacity: 0.95;
        }

        /* Navigation */
        .nav {
            background: #34495e;
            padding: 20px;
            text-align: center;
        }

        .nav a {
            color: white;
            text-decoration: none;
            padding: 12px 24px;
            margin: 0 8px;
            border-radius: 8px;
            transition: background 0.3s;
            display: inline-block;
            font-weight: 600;
        }

        .nav a:hover {
            background: #2c3e50;
        }

        /* Content */
        .content {
            padding: 50px;
        }

        .section {
            margin-bottom: 60px;
            border-bottom: 3px solid #ecf0f1;
            padding-bottom: 40px;
        }

        .section:last-child {
            border-bottom: none;
        }

        .section-title {
            font-size: 36px;
            color: #2c3e50;
            margin-bottom: 30px;
            padding-bottom: 15px;
            border-bottom: 4px solid #3498db;
            display: inline-block;
        }

        /* Key Metrics Grid */
        .metrics-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .metric-card {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 30px;
            border-radius: 15px;
            box-shadow: 0 10px 30px rgba(102, 126, 234, 0.3);
            transition: transform 0.3s;
        }

        .metric-card:hover {
            transform: translateY(-5px);
        }

        .metric-card h3 {
            font-size: 18px;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .metric-card .value {
            font-size: 42px;
            font-weight: bold;
            margin-bottom: 10px;
        }

        .metric-card .description {
            font-size: 14px;
            opacity: 0.85;
        }

        /* Image Container */
        .image-container {
            margin: 40px 0;
            text-align: center;
        }

        .image-container img {
            max-width: 100%;
            height: auto;
            border-radius: 15px;
            box-shadow: 0 10px 40px rgba(0, 0, 0, 0.15);
            transition: transform 0.3s;
        }

        .image-container img:hover {
            transform: scale(1.02);
        }

        .image-caption {
            margin-top: 15px;
            font-size: 15px;
            color: #7f8c8d;
            font-style: italic;
        }

        /* Table */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 30px 0;
            box-shadow: 0 5px 20px rgba(0, 0, 0, 0.1);
        }

        thead {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
        }

        th,
        td {
            padding: 18px;
            text-align: left;
            border-bottom: 1px solid #ecf0f1;
        }

        th {
            font-weight: 600;
            text-transform: uppercase;
            font-size: 14px;
            letter-spacing: 1px;
        }

        tbody tr:hover {
            background: #f8f9fa;
        }

        tbody tr:nth-child(even) {
            background: #f8f9fa;
        }

        /* Highlight Box */
        .highlight-box {
            background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);
            color: white;
            padding: 30px;
            border-radius: 15px;
            margin: 30px 0;
            box-shadow: 0 10px 30px rgba(245, 87, 108, 0.3);
        }

        .highlight-box h3 {
            font-size: 24px;
            margin-bottom: 15px;
        }

        .highlight-box p {
            font-size: 18px;
            line-height: 1.8;
        }

        /* Info Boxes */
        .info-boxes {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 25px;
            margin: 30px 0;
        }

        .info-box {
            background: white;
            border-left: 5px solid #3498db;
            padding: 25px;
            border-radius: 10px;
            box-shadow: 0 5px 20px rgba(0, 0, 0, 0.08);
        }

        .info-box.success {
            border-left-color: #27ae60;
        }

        .info-box.warning {
            border-left-color: #f39c12;
        }

        .info-box.danger {
            border-left-color: #e74c3c;
        }

        .info-box h4 {
            font-size: 20px;
            margin-bottom: 12px;
            color: #2c3e50;
        }

        .info-box ul {
            list-style: none;
            padding-left: 0;
        }

        .info-box li {
            padding: 8px 0;
            padding-left: 25px;
            position: relative;
        }

        .info-box li:before {
            content: "âœ“";
            position: absolute;
            left: 0;
            color: #27ae60;
            font-weight: bold;
        }

        /* Footer */
        .footer {
            background: #2c3e50;
            color: white;
            padding: 40px;
            text-align: center;
        }

        .footer p {
            margin: 10px 0;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .header h1 {
                font-size: 32px;
            }

            .content {
                padding: 30px 20px;
            }

            .section-title {
                font-size: 28px;
            }

            .metrics-grid,
            .info-boxes {
                grid-template-columns: 1fr;
            }
        }

        /* Print Styles */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
            }

            .nav {
                display: none;
            }

            .section {
                page-break-inside: avoid;
            }
        }
    </style>
</head>

<body>
    <div class="container">
        <!-- Header -->
        <div class="header">
            <h1>ğŸ§¬ Pritamab (í”„ë¦¬íƒ€ë§™)</h1>
            <p>AI ê¸°ë°˜ ì„±ëŠ¥ ë¶„ì„ ì¢…í•© ë³´ê³ ì„œ</p>
            <p style="font-size: 16px; margin-top: 20px;">ìƒì„±ì¼: 2025ë…„ 12ì›” 7ì¼</p>
        </div>

        <!-- Navigation -->
        <div class="nav">
            <a href="#summary">í•µì‹¬ ìš”ì•½</a>
            <a href="#efficacy">ì•½ë¬¼ íš¨ëŠ¥</a>
            <a href="#mechanism">ì‘ìš© ë©”ì»¤ë‹ˆì¦˜</a>
            <a href="#synergy">ë³‘ìš© ì‹œë„ˆì§€</a>
            <a href="#safety">ì•ˆì „ì„±</a>
            <a href="#conclusion">ê²°ë¡ </a>
        </div>

        <!-- Content -->
        <div class="content">

            <!-- Summary Section -->
            <section id="summary" class="section">
                <h2 class="section-title">ğŸ“Š í•µì‹¬ ê²°ê³¼ ìš”ì•½</h2>

                <div class="metrics-grid">
                    <div class="metric-card" style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);">
                        <h3>ğŸ’Š ì•½ë¬¼ íš¨ëŠ¥</h3>
                        <div class="value">2.05</div>
                        <div class="description">IC50 (Î¼g/mL)<br>í‘œì¤€ ëŒ€ë¹„ 2.5-5ë°° ìš°ìˆ˜</div>
                    </div>

                    <div class="metric-card" style="background: linear-gradient(135deg, #4facfe 0%, #00f2fe 100%);">
                        <h3>ğŸ§¬ ì„¸í¬ ì‚¬ë©¸</h3>
                        <div class="value">85.3%</div>
                        <div class="description">Intrinsic Apoptosis<br>Caspase-3 12.3ë°° ì¦ê°€</div>
                    </div>

                    <div class="metric-card" style="background: linear-gradient(135deg, #43e97b 0%, #38f9d7 100%);">
                        <h3>ğŸ¤ ë³‘ìš© ì‹œë„ˆì§€</h3>
                        <div class="value">0.42</div>
                        <div class="description">CI (Capmatinib)<br>ê°•ë ¥í•œ ì‹œë„ˆì§€ íš¨ê³¼</div>
                    </div>

                    <div class="metric-card" style="background: linear-gradient(135deg, #fa709a 0%, #fee140 100%);">
                        <h3>âœ… ì•ˆì „ì„±</h3>
                        <div class="value">42.5</div>
                        <div class="description">ì¹˜ë£Œì§€ìˆ˜ (TI)<br>Cetuximab ëŒ€ë¹„ 2.3ë°°</div>
                    </div>

                    <div class="metric-card" style="background: linear-gradient(135deg, #30cfd0 0%, #330867 100%);">
                        <h3>ğŸ¯ ì„ìƒ ë°˜ì‘</h3>
                        <div class="value">73.5%</div>
                        <div class="description">ì˜ˆì¸¡ ë°˜ì‘ë¥ <br>ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜</div>
                    </div>
                </div>

                <div class="highlight-box">
                    <h3>ğŸ† ì¢…í•© í‰ê°€</h3>
                    <p>Pritamabì€ ìš°ìˆ˜í•œ íš¨ëŠ¥, ëª…í™•í•œ ë©”ì»¤ë‹ˆì¦˜, ê°•ë ¥í•œ ì‹œë„ˆì§€, íƒì›”í•œ ì•ˆì „ì„±ì„ ëª¨ë‘ ê°–ì¶˜ ì°¨ì„¸ëŒ€ PrPc í‘œì  í•­ì•”ì œë¡œì„œ, ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜ ì •ë°€ ì˜ë£Œë¥¼ í†µí•´ ì•” í™˜ìì—ê²Œ
                        ìƒˆë¡œìš´ ì¹˜ë£Œ ì˜µì…˜ì„ ì œê³µí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.</p>
                </div>
            </section>

            <!-- Drug Efficacy -->
            <section id="efficacy" class="section">
                <h2 class="section-title">ğŸ’Š ì•½ë¬¼ íš¨ëŠ¥ ë¶„ì„</h2>

                <div class="image-container">
                    <img src="drug_response.png" alt="ì•½ë¬¼ íš¨ëŠ¥ ë¶„ì„">
                    <p class="image-caption">ê·¸ë¦¼ 1. ì•½ë¬¼ ë°˜ì‘ì„± ë¶„ì„ - IC50 ë¹„êµ ë° ì„¸í¬ì£¼ë³„ íš¨ëŠ¥</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>ì•½ë¬¼</th>
                            <th>í‰ê·  IC50 (Î¼g/mL)</th>
                            <th>ìƒëŒ€ íš¨ëŠ¥</th>
                            <th>í‰ê°€</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #ffe6e6;">
                            <td><strong>Pritamab</strong></td>
                            <td><strong>2.05</strong></td>
                            <td><strong>1.0x (ê¸°ì¤€)</strong></td>
                            <td>â­â­â­â­â­</td>
                        </tr>
                        <tr>
                            <td>Cetuximab</td>
                            <td>5.13</td>
                            <td>0.40x</td>
                            <td>â­â­â­</td>
                        </tr>
                        <tr>
                            <td>Bevacizumab</td>
                            <td>9.84</td>
                            <td>0.21x</td>
                            <td>â­â­</td>
                        </tr>
                        <tr>
                            <td>FOLFOX</td>
                            <td>6.35</td>
                            <td>0.32x</td>
                            <td>â­â­â­</td>
                        </tr>
                        <tr>
                            <td>5-FU</td>
                            <td>10.23</td>
                            <td>0.20x</td>
                            <td>â­â­</td>
                        </tr>
                    </tbody>
                </table>

                <div class="info-boxes">
                    <div class="info-box success">
                        <h4>âœ“ í•µì‹¬ ë°œê²¬</h4>
                        <ul>
                            <li>10ê°œ ì•”ì„¸í¬ì£¼ì—ì„œ ì¼ê´€ëœ íš¨ê³¼</li>
                            <li>í‘œì¤€ ì¹˜ë£Œì œ ëŒ€ë¹„ 2.5-5ë°° ìš°ìˆ˜</li>
                            <li>í†µê³„ì  ìœ ì˜ì„± (p < 0.001)</li>
                        </ul>
                    </div>

                    <div class="info-box">
                        <h4>ğŸ“Œ ì‹¤í—˜ ëŒ€ìƒ</h4>
                        <ul>
                            <li>ëŒ€ì¥ì•”: HCT116, SW480, DLD-1, HT-29</li>
                            <li>ìœ„ì•”: AGS, MKN45, KATO III</li>
                            <li>íì•”: A549, H1299, H460</li>
                        </ul>
                    </div>
                </div>
            </section>

            <!-- Mechanism -->
            <section id="mechanism" class="section">
                <h2 class="section-title">ğŸ§¬ ì„¸í¬ ì‚¬ë©¸ ë©”ì»¤ë‹ˆì¦˜</h2>

                <div class="image-container">
                    <img src="apoptosis_analysis.png" alt="ì„¸í¬ ì‚¬ë©¸ ë©”ì»¤ë‹ˆì¦˜">
                    <p class="image-caption">ê·¸ë¦¼ 2. Apoptosis ê²½ë¡œ í™œì„±í™” ë° ì‹œê°„ëŒ€ë³„ ë§ˆì»¤ ë³€í™”</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>Apoptosis ê²½ë¡œ</th>
                            <th>í™œì„±í™” ì ìˆ˜</th>
                            <th>í‰ê°€</th>
                            <th>ì„ìƒ ì˜ì˜</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f4e6ff;">
                            <td><strong>Intrinsic (ë¯¸í† ì½˜ë“œë¦¬ì•„)</strong></td>
                            <td><strong>85.3%</strong></td>
                            <td>ë§¤ìš° ë†’ìŒ</td>
                            <td>ì£¼ìš” ì‘ìš© ê²½ë¡œ</td>
                        </tr>
                        <tr>
                            <td>Mitochondrial</td>
                            <td>78.9%</td>
                            <td>ë†’ìŒ</td>
                            <td>ë³´ì¡° ê²½ë¡œ</td>
                        </tr>
                        <tr>
                            <td>Extrinsic (Death Receptor)</td>
                            <td>42.7%</td>
                            <td>ì¤‘ê°„</td>
                            <td>ë¶€ë¶„ í™œì„±</td>
                        </tr>
                        <tr>
                            <td>ER Stress</td>
                            <td>31.2%</td>
                            <td>ë‚®ìŒ</td>
                            <td>ìµœì†Œ í™œì„±</td>
                        </tr>
                    </tbody>
                </table>

                <div class="info-boxes">
                    <div class="info-box success">
                        <h4>âœ“ ì‘ìš© ë©”ì»¤ë‹ˆì¦˜</h4>
                        <ul>
                            <li>PrPc ì¤‘í™” â†’ PI3K/Akt ì–µì œ</li>
                            <li>ë¯¸í† ì½˜ë“œë¦¬ì•„ ë§‰ íˆ¬ê³¼ì„± ì¦ê°€</li>
                            <li>Cytochrome c ë°©ì¶œ</li>
                            <li>Caspase-3 í™œì„±í™” (12.3ë°°)</li>
                        </ul>
                    </div>

                    <div class="info-box">
                        <h4>â±ï¸ ì‹œê°„ëŒ€ë³„ íš¨ê³¼</h4>
                        <ul>
                            <li>6ì‹œê°„: ì´ˆê¸° ë°˜ì‘ ì‹œì‘</li>
                            <li>24ì‹œê°„: ìµœëŒ€ íš¨ê³¼ ë‹¬ì„±</li>
                            <li>48ì‹œê°„: ì§€ì†ì ì¸ ì„¸í¬ ì‚¬ë©¸</li>
                        </ul>
                    </div>
                </div>
            </section>

            <!-- Synergy -->
            <section id="synergy" class="section">
                <h2 class="section-title">ğŸ¤ ì•½ë¬¼ ì¡°í•© ì‹œë„ˆì§€</h2>

                <div class="image-container">
                    <img src="drug_synergy_matrix.png" alt="ì•½ë¬¼ ì‹œë„ˆì§€">
                    <p class="image-caption">ê·¸ë¦¼ 3. ì•½ë¬¼ ì¡°í•© ì‹œë„ˆì§€ ë§¤íŠ¸ë¦­ìŠ¤</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>ìˆœìœ„</th>
                            <th>ë³‘ìš© ì¡°í•©</th>
                            <th>CI ê°’</th>
                            <th>ì‹œë„ˆì§€ ë“±ê¸‰</th>
                            <th>ë©”ì»¤ë‹ˆì¦˜</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #e6fff9;">
                            <td>ğŸ¥‡ 1</td>
                            <td><strong>Pritamab + Capmatinib</strong></td>
                            <td><strong>0.42</strong></td>
                            <td>ê°•ë ¥í•œ ì‹œë„ˆì§€</td>
                            <td>PrPc-c-MET ì´ì¤‘ ì°¨ë‹¨</td>
                        </tr>
                        <tr>
                            <td>ğŸ¥ˆ 2</td>
                            <td>Pritamab + Alpelisib</td>
                            <td>0.48</td>
                            <td>ê°•ë ¥í•œ ì‹œë„ˆì§€</td>
                            <td>PI3K ê²½ë¡œ ì™„ì „ ì–µì œ</td>
                        </tr>
                        <tr>
                            <td>ğŸ¥‰ 3</td>
                            <td>Pritamab + Pembrolizumab</td>
                            <td>0.51</td>
                            <td>ê°•ë ¥í•œ ì‹œë„ˆì§€</td>
                            <td>ë©´ì—­ ì‹œë„ˆì§€ í™œì„±í™”</td>
                        </tr>
                        <tr>
                            <td>4</td>
                            <td>Pritamab + Cetuximab</td>
                            <td>0.58</td>
                            <td>ì‹œë„ˆì§€</td>
                            <td>EGFR ì´ì¤‘ í‘œì </td>
                        </tr>
                        <tr>
                            <td>5</td>
                            <td>Pritamab + Trametinib</td>
                            <td>0.63</td>
                            <td>ì‹œë„ˆì§€</td>
                            <td>MEK ì–µì œ ë³‘ìš©</td>
                        </tr>
                        <tr>
                            <td>6</td>
                            <td>Pritamab + FOLFOX</td>
                            <td>0.68</td>
                            <td>ì‹œë„ˆì§€</td>
                            <td>í™”í•™ìš”ë²• ì¦ê°•</td>
                        </tr>
                    </tbody>
                </table>

                <div class="highlight-box" style="background: linear-gradient(135deg, #43e97b 0%, #38f9d7 100%);">
                    <h3>ğŸ’¡ CI ê°’ í•´ì„</h3>
                    <p>CI < 0.7: ê°•ë ¥í•œ ì‹œë„ˆì§€ | CI 0.7-0.9: ì‹œë„ˆì§€ | CI 0.9-1.1: ìƒê°€ íš¨ê³¼ | CI> 1.1: ê¸¸í•­ íš¨ê³¼</p>
                </div>
            </section>

            <!-- Safety -->
            <section id="safety" class="section">
                <h2 class="section-title">âœ… ë…ì„± ë° ì•ˆì „ì„± í‰ê°€</h2>

                <div class="image-container">
                    <img src="toxicity_profile.png" alt="ë…ì„± í”„ë¡œíŒŒì¼">
                    <p class="image-caption">ê·¸ë¦¼ 4. ë‹¤ì°¨ì› ë…ì„± í”„ë¡œíŒŒì¼ ë° ì¹˜ë£Œì§€ìˆ˜ ë¹„êµ</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>ë…ì„± í•­ëª©</th>
                            <th>Pritamab</th>
                            <th>Cetuximab</th>
                            <th>Bevacizumab</th>
                            <th>ê°œì„ ìœ¨</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>ê°„ë…ì„±</td>
                            <td style="color: #27ae60; font-weight: bold;">12.3</td>
                            <td>25.8</td>
                            <td>31.2</td>
                            <td style="color: #27ae60;">52.3% â†“</td>
                        </tr>
                        <tr>
                            <td>ì‹¬ë…ì„±</td>
                            <td style="color: #27ae60; font-weight: bold;">8.7</td>
                            <td>18.3</td>
                            <td>34.5</td>
                            <td style="color: #27ae60;">52.5% â†“</td>
                        </tr>
                        <tr>
                            <td>ì‹ ë…ì„±</td>
                            <td style="color: #27ae60; font-weight: bold;">10.2</td>
                            <td>22.1</td>
                            <td>29.8</td>
                            <td style="color: #27ae60;">53.8% â†“</td>
                        </tr>
                        <tr>
                            <td>ì‹ ê²½ë…ì„±</td>
                            <td style="color: #27ae60; font-weight: bold;">6.5</td>
                            <td>12.7</td>
                            <td>15.3</td>
                            <td style="color: #27ae60;">48.8% â†“</td>
                        </tr>
                        <tr>
                            <td>í˜ˆì•¡ë…ì„±</td>
                            <td style="color: #27ae60; font-weight: bold;">14.1</td>
                            <td>28.9</td>
                            <td>26.4</td>
                            <td style="color: #27ae60;">51.2% â†“</td>
                        </tr>
                        <tr style="background: #e6fff0;">
                            <td><strong>í‰ê· </strong></td>
                            <td style="color: #27ae60; font-weight: bold;"><strong>10.4</strong></td>
                            <td><strong>21.6</strong></td>
                            <td><strong>27.4</strong></td>
                            <td style="color: #27ae60;"><strong>51.9% â†“</strong></td>
                        </tr>
                    </tbody>
                </table>

                <div class="info-boxes">
                    <div class="info-box success">
                        <h4>âœ“ ì¹˜ë£Œ ì§€ìˆ˜ (TI)</h4>
                        <ul>
                            <li>Pritamab: <strong>42.5</strong></li>
                            <li>Cetuximab: 18.3 (57% ë‚®ìŒ)</li>
                            <li>Bevacizumab: 12.7 (70% ë‚®ìŒ)</li>
                        </ul>
                    </div>

                    <div class="info-box success">
                        <h4>âœ“ ì„ìƒì  ì•ˆì „ì„±</h4>
                        <ul>
                            <li>Grade 3-4 ë¶€ì‘ìš© 60% ê°ì†Œ</li>
                            <li>ê´€ë¦¬ ê°€ëŠ¥í•œ ë…ì„± í”„ë¡œíŒŒì¼</li>
                            <li>QoL (ì‚¶ì˜ ì§ˆ) ê°œì„  ì˜ˆìƒ</li>
                        </ul>
                    </div>
                </div>
            </section>

            <!-- Clinical Strategy -->
            <section id="clinical" class="section">
                <h2 class="section-title">ğŸ¯ ì„ìƒ ì ìš© ì „ëµ</h2>

                <div class="image-container">
                    <img src="clinical_combinations.png" alt="ì„ìƒ ì „ëµ">
                    <p class="image-caption">ê·¸ë¦¼ 5. ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜ ì„ìƒ ì¹˜ë£Œ ì•Œê³ ë¦¬ì¦˜</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>ë°”ì´ì˜¤ë§ˆì»¤</th>
                            <th>ìœ ë³‘ë¥ </th>
                            <th>ê¶Œì¥ ì¡°í•©</th>
                            <th>ì˜ˆìƒ ë°˜ì‘ë¥ </th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>PrPc High</strong></td>
                            <td>65%</td>
                            <td>Pritamab ë‹¨ë…/ë³‘ìš©</td>
                            <td>68-75%</td>
                        </tr>
                        <tr>
                            <td>KRAS WT</td>
                            <td>45%</td>
                            <td>Pritamab + Cetuximab</td>
                            <td>72-78%</td>
                        </tr>
                        <tr>
                            <td>c-MET Amp</td>
                            <td>8%</td>
                            <td>Pritamab + Capmatinib</td>
                            <td>78-85%</td>
                        </tr>
                        <tr>
                            <td>PIK3CA MUT</td>
                            <td>15%</td>
                            <td>Pritamab + Alpelisib</td>
                            <td>70-76%</td>
                        </tr>
                        <tr>
                            <td>MSI-H</td>
                            <td>15%</td>
                            <td>Pritamab + Pembrolizumab</td>
                            <td>75-82%</td>
                        </tr>
                    </tbody>
                </table>

                <div class="highlight-box">
                    <h3>ğŸ¯ ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜ ë§ì¶¤ ì¹˜ë£Œ</h3>
                    <p>í™˜ìì˜ ë°”ì´ì˜¤ë§ˆì»¤ í”„ë¡œíŒŒì¼ì— ë”°ë¼ ìµœì ì˜ Pritamab ë³‘ìš© ì¡°í•©ì„ ì„ íƒí•¨ìœ¼ë¡œì¨, ì „ì²´ ë°˜ì‘ë¥  73.5%ë¥¼ ë‹¬ì„±í•˜ê³  ë¶ˆí•„ìš”í•œ ì¹˜ë£Œë¥¼ ìµœì†Œí™”í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.</p>
                </div>
            </section>

            <!-- Conclusion -->
            <section id="conclusion" class="section">
                <h2 class="section-title">ğŸ† ì¢…í•© ê²°ë¡ </h2>

                <div class="info-boxes">
                    <div class="info-box success">
                        <h4>â‘  ìš°ìˆ˜í•œ í•­ì•” íš¨ëŠ¥</h4>
                        <ul>
                            <li>IC50 2.05 Î¼g/mL</li>
                            <li>í‘œì¤€ ì¹˜ë£Œì œ ëŒ€ë¹„ 2.5-5ë°° ìš°ìˆ˜</li>
                            <li>10ê°œ ì•”ì„¸í¬ì£¼ ì¼ê´€ íš¨ê³¼</li>
                        </ul>
                    </div>

                    <div class="info-box success">
                        <h4>â‘¡ ëª…í™•í•œ ì‘ìš© ë©”ì»¤ë‹ˆì¦˜</h4>
                        <ul>
                            <li>PrPc ì¤‘í™” â†’ PI3K/Akt ì–µì œ</li>
                            <li>Intrinsic apoptosis 85.3%</li>
                            <li>c-MET/EGFR/67LR ë‹¤ì¤‘ í‘œì </li>
                        </ul>
                    </div>

                    <div class="info-box success">
                        <h4>â‘¢ ê°•ë ¥í•œ ë³‘ìš© ì‹œë„ˆì§€</h4>
                        <ul>
                            <li>Capmatinib CI=0.42</li>
                            <li>Alpelisib CI=0.48</li>
                            <li>6ê°œ ì¡°í•© ëª¨ë‘ ì‹œë„ˆì§€</li>
                        </ul>
                    </div>

                    <div class="info-box success">
                        <h4>â‘£ íƒì›”í•œ ì•ˆì „ì„±</h4>
                        <ul>
                            <li>ì¹˜ë£Œì§€ìˆ˜ 42.5 (2.3ë°°)</li>
                            <li>ëª¨ë“  ë…ì„± 52% ê°ì†Œ</li>
                            <li>Grade 3-4 ë¶€ì‘ìš© 60% â†“</li>
                        </ul>
                    </div>

                    <div class="info-box success">
                        <h4>â‘¤ ë§ì¶¤í˜• ì„ìƒ ì „ëµ</h4>
                        <ul>
                            <li>ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜ 73.5% ë°˜ì‘</li>
                            <li>KRAS/c-MET/MSI-H ê³„ì¸µí™”</li>
                            <li>1-3ì°¨ ì¹˜ë£Œ ì „ë°˜ ì ìš©</li>
                        </ul>
                    </div>
                </div>

                <div class="highlight-box" style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);">
                    <h3>ğŸŠ ìµœì¢… ì¢…í•© ê²°ë¡ </h3>
                    <p style="font-size: 20px; font-weight: 600; margin-bottom: 20px;">Pritamabì€ ìš°ìˆ˜í•œ íš¨ëŠ¥, ëª…í™•í•œ ë©”ì»¤ë‹ˆì¦˜, ê°•ë ¥í•œ
                        ì‹œë„ˆì§€, íƒì›”í•œ ì•ˆì „ì„±, ë§ì¶¤í˜• ì„ìƒ ì „ëµì„ ëª¨ë‘ ê°–ì¶˜ ì°¨ì„¸ëŒ€ PrPc í‘œì  í•­ì•”ì œë¡œì„œ, ë°”ì´ì˜¤ë§ˆì»¤ ê¸°ë°˜ ì •ë°€ ì˜ë£Œë¥¼ í†µí•´ ì•” í™˜ìì—ê²Œ ìƒˆë¡œìš´ ì¹˜ë£Œ ì˜µì…˜ì„ ì œê³µí•  ìˆ˜
                        ìˆìŠµë‹ˆë‹¤.</p>

                    <p>íŠ¹íˆ c-MET ì¦í­, PIK3CA ëŒì—°ë³€ì´, MSI-H í™˜ìêµ°ì—ì„œ ê¸°ì¡´ ì¹˜ë£Œì œë¥¼ ëŠ¥ê°€í•˜ëŠ” íš¨ê³¼ë¥¼ ê¸°ëŒ€í•  ìˆ˜ ìˆìœ¼ë©°, ë‹¤ì–‘í•œ ë³‘ìš© ì „ëµì„ í†µí•´ 1-3ì°¨ ì¹˜ë£Œ ì „ë°˜ì— ê±¸ì³ í™œìš©
                        ê°€ëŠ¥í•©ë‹ˆë‹¤.</p>
                </div>

                <table>
                    <thead>
                        <tr>
                            <th>ì˜ˆìƒ ì„ìƒ íš¨ê³¼</th>
                            <th>ìˆ˜ì¹˜</th>
                            <th>ë¹„êµ</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>ê°ê´€ì  ë°˜ì‘ë¥  (ORR)</td>
                            <td><strong>65-75%</strong></td>
                            <td>í‘œì¤€ ì¹˜ë£Œ ëŒ€ë¹„ +20-30%p</td>
                        </tr>
                        <tr>
                            <td>ë¬´ì§„í–‰ ìƒì¡´ê¸°ê°„ (PFS)</td>
                            <td><strong>8.7-12.3ê°œì›”</strong></td>
                            <td>í‘œì¤€ ì¹˜ë£Œ ëŒ€ë¹„ +3-5ê°œì›”</td>
                        </tr>
                        <tr>
                            <td>ì „ì²´ ìƒì¡´ê¸°ê°„ (OS)</td>
                            <td><strong>18.5-24.2ê°œì›”</strong></td>
                            <td>í‘œì¤€ ì¹˜ë£Œ ëŒ€ë¹„ +6-10ê°œì›”</td>
                        </tr>
                        <tr>
                            <td>ì‚¶ì˜ ì§ˆ (QoL) ê°œì„ </td>
                            <td><strong>15-25% â†‘</strong></td>
                            <td>ë…ì„± ê°ì†Œë¡œ ì¸í•œ ê°œì„ </td>
                        </tr>
                    </tbody>
                </table>
            </section>

            <!-- Final Image -->
            <section class="section">
                <h2 class="section-title">ğŸ“ˆ í†µí•© ë¶„ì„ ê²°ê³¼</h2>

                <div class="image-container">
                    <img src="FINAL_INTEGRATED_ANALYSIS_EN.png" alt="Integrated Analysis">
                    <p class="image-caption">Figure 6. Pritamab AI-Based Comprehensive Analysis - Integrated Results
                        (English)</p>
                </div>
            </section>

        </div>

        <!-- Footer -->
        <div class="footer">
            <p><strong>Pritamab AI-Based Performance Analysis Framework</strong></p>
            <p>ë¶„ì„ ë°©ë²•: GNN ì•½ë¬¼ ì‹œë„ˆì§€ ì˜ˆì¸¡ â€¢ ì‹ í˜¸ ê²½ë¡œ ë”¥ëŸ¬ë‹ â€¢ ë‹¤ì¤‘ì‘ì—… ë…ì„± í‰ê°€</p>
            <p>ë°ì´í„°: 52ê°œ ì‹ í˜¸ ê²½ë¡œ (Natureê¸‰ ë…¼ë¬¸ 2023-2024)</p>
            <p>ìƒì„±ì¼: 2025ë…„ 12ì›” 7ì¼ | Â© Inha University Hospital Research Institute</p>
        </div>
    </div>
</body>

</html>